Skip to content
Betcore Hub

Patients Stopping Slimming Injections Gain Back Weight at a Quadrupled Rate Compared to Dieters

Illustration of medical injection and scale
Obesity treatment involves long-term strategies.

A recent study indicates that people who stop using blockbuster weight-loss injections like Wegovy and Mounjaro can put back on reduced body mass much more quickly than those who end conventional diet and exercise plans.

Research printed in a major health publication shows that while overweight people frequently drop a large proportion of their body weight while undergoing treatment, the mass is regained at an average rate of 0.8 kg per month after stopping.

"People buying such drugs must be cognizant of the danger of quick rebound weight gain when the therapy concludes," warns expert Dr. Susan Jebb.

That rate of regain implies a reversion to pre-treatment mass within about a year and a half.

Comparing Therapies

The study, which looked at 37 of studies involving thousands of patients, contrasted the effects of GLP-1 agonists with other pills.

Researchers note that individuals who lose weight through dieting usually have a more gradual weight regain—around 100 grams monthly—once they finish.

Understanding the Quick Rebound

Experts propose the mechanism of the drugs is key to understanding the amplified regain.

GLP-1 drugs imitate a natural hormone called GLP-1, which controls feelings of fullness.

"Long-term administration of the hormone concentrations far above than normal might result in the body to produce less of its own natural GLP-1, and may also lessen sensitivity to its effects," explained Dr. Adam Collins, a dietetics specialist.

"Withdrawal of this hormone supplement means appetite is no longer kept in check, making binge eating much more probable."

A Lifelong Condition?

Medical guidelines suggest the jabs for people with weight-linked health risks, accompanied by prescribed lifestyle changes.

Professionals argue that, due to the high risk of weight regain, the treatment should be considered ongoing.

This view is supported by pharmaceutical companies, who say that the findings "emphasize the chronic character of excess weight," comparing it to managing conditions like hypertension.

Patient Accounts

Individuals who have come off the medication describe a sudden resurgence of appetite.

"I experienced something that goes on and you're instantly ravenous," recalled a patient.

The struggle is compounded if patients have not established sustainable lifestyle or habit changes during therapy.

Widespread Use

Recent estimates show that a significant number of adults in the UK have tried these injections in the last 12 months, with interest continuing to grow.

  • Adoption is more common among women than males.
  • The 40s and 50s age group shows the greatest level of interest.
  • A large proportion access the medications through private healthcare rather than public health services.

Finally, researchers stress that while these medications are powerful agents for weight loss, they are not a permanent cure and long-term success likely depends on combined behavioural changes.

JJ
By

Jessica Jacobs

A seasoned sports analyst with over a decade of experience in betting markets, specializing in football and horse racing strategies.

Betcore Hub

Type to search articles.